22.30NOK+1.36%Mkt Cap: 62.25M $P/E: —Today
Zelluna ASA, a clinical-stage biotechnology company, engages in the development of T-cell receptor guided natural killer cell therapies in Norway. It develops ZI-MA4-1 which is in Phase I clinical trial for the treatment…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap62.25M $
Enterprise Value49.44M $
Revenue (TTM)748 $
Gross Profit748 $
Net Income (TTM)-13.15M $
Revenue/Share0.0000 USD
Last Price22.30 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees15
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINNO0013524942
Valuation
P/E (Trailing)—
P/E (Forward)-2.77
PEG—
EV/EBITDA-4.21
EV/Revenue66118.08
P/S80623.38
P/B8.46
EPS (TTM)-7.50
EPS (Forward)-7.80
52W Range
8.20451% of range35.80
52W High35.80 NOK
52W Low8.204 NOK
Profitability
Gross Margin100.00%
Oper. Margin-254312.50%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-46.84%
ROA-45.67%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.93M $
CapEx (TTM)33.56K $
FCF Margin-1186650.00%
FCF Yield-14.26%
Net Debt-4.58M $
Net Debt/EBITDA0.39
Balance Sheet
Debt/Equity0.00
Current Ratio6.70
Quick Ratio6.48
Book Value/Sh2.552 NOK
Cash/Share1.878 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 1, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.29.86M
Float12.06M
Insiders42.00%
Institutions15.72%
Technical
SMA 5020.76 (+7.4%)
SMA 20017.54 (+27.1%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)31.02K
Avg Vol (10d)44.69K
Technical Indicators
RSI (14)51.5
MACD0.2200
MACD Signal0.3352
MACD Hist.-0.1151
BB Upper23.34 NOK
BB Middle22.14 NOK
BB Lower20.93 NOK
BB Width10.86%
ATR (14)1.315 NOK
Vol Ratio (20d)1.44x